Drug for Diabetic Nephropathy in Phase 3 TrialJuly 7th, 2005 Speedel announced today the start of its Phase III study for SPP301, its once-a-day oral endothelin A receptor antagonist (ERA) in the indication of diabetic nephropathy (diabetic kidney disease). The ASCEND(1) study has begun with the first patient visit as per the schedule outlined by Speedel in March 2005 when the company reported successful completion of the Phase II clinical trials.
AIIMS / Indian Government Ideal For DCA Human Trial For Cancer TreatmentFebruary 5th, 2007 India is the ideal place to conduct human trial for the effectiveness of DCA ( dichloroacetate ) as anti-cancer drug. The government regulations for human trial aren't as stringest as USA, there are funds available for such studies and frankly you don't need much.
One-day Treatment with the Anticancer Drug Carboplatin is as Effective as Radiotherapy for Testicular CancerJuly 21st, 2005 One-day treatment with the anticancer drug carboplatin is as
effective and less toxic than three weeks radiation therapy for a type
of testicular cancer, according to a report published in this week's
issue of The Lancet. For the last 50 years standard care for stage 1 seminoma - a cancer of the testes - has been surgical removal of the cancerous testicle (hemi-castration) followed by three weeks radiotherapy.
INGAP closer to cure diabetesMarch 18th, 2005 LOS ANGELES -- Researchers might be getting closer to finding a cure for diabetes. Researchers announced a new treatment and medicine, and the discovery of a gene that might play a role.
Breaking News: European Study Reports Halting of Progress of Type 1 Diabetes by Drug Anti-CD3 AntibodyJuly 17th, 2005 The European study of patients with Type I diabetes found that short-term treatment lowered insulin dependence by 12 percent and increased insulin-making capabilities for at least 18 months. "The results are very promising.
Ruboxistaurin (RBX) May Reduce Risk of Vision Loss in DiabeticsJuly 16th, 2005 A multicenter international study chaired by a Joslin Diabetes Center investigator and reported in the July issue of the American Diabetes Association’s journal Diabetes brings hopeful news to the 18 million people in the United States -- and millions more worldwide -- with type 1 or type 2 diabetes. Initial results of the Phase III clinical trial demonstrated that 32 milligrams per day of ruboxistaurin (RBX) was well tolerated and may reduce the risk of moderate vision loss, especially in patients with diabetic macular edema.
New Therapy for Diabetic Peripheral Neuropathy using monochromatic infrared photo energyApril 7th, 2005 for those afflicted with Diabetic Peripheral Neuropathy (DPN), Missouri Southern Healthcare has a new therapy program that has shown great strides in returning circulation to feet, lowering the pain and frequency of falls that most people with diabetes suffer. The therapy must be given in 40-minute increments three times a week for 10 to 20 weeks.
Diabetes Treatment by Consuming TeaAugust 9th, 2005 Study conducted by researchers at the University of Scranton suggests that tea might prevent diabetes and its associated complications, including diabetic cataracts. Researchers led by Joe Vinson fed green and black tea to diabetic rats for three months and then monitored the chemical composition of the rats' blood and eye lenses.
Gene expression inhibitor drug made mice (STZ induced) diabetes resistantMarch 21st, 2005 Researchers from North Shore-Long Island Jewish Health System in Manhasset, N.Y. have identified a gene which expresses as a protein called macrophage migration inhibitory factor, or MIF.
Self-Treatment With DCA for CancerFebruary 27th, 2007 DCA has generated quite an interest in patients with Cancer, many even contemplating self-treatment for cure. The key points we know about DCA so far are:
1.
FDA OK's Cholesterol Drug Lipitor for DiabeticsSeptember 27th, 2005 Pfizer Inc. said U.S. regulators (FDA) have approved its cholesterol lowering drug Lipitor. Lipitor is used to reduce the risk of stroke and heart attack in diabetic patients.
Diabulimia: Forced Weight Loss by Diabetics Can KillJune 19th, 2007 Diabulimia is a new term used to describe an eating disorder that’s beginning to victimize type I diabetics. As with any other eating disorder teens are the most likely to develop it.
New hope for people with hepatitis CMay 23rd, 2005 University of New South Wales (UNSW) researchers are running two new studies on hepatitis C, which could revolutionise treatment for the virus. It is hoped that one study could lead to cure rates of almost 100 percent in those who have just been infected with the virus.
New Foot Surgery Method Helps in Neuropathy; May Prevent AmputationsMarch 13th, 2005 Diabetic foot care experts presenting at the American College of Foot and Ankle Surgeons Annual Scientific Conference said that foot and ankle surgeons are pioneering an approach to relieve pressure on nerves in diabetic feet that cause loos of sensation and foot ulcers. "The new surgical approach is to release the tarsal tunnel to decompress the nerve and allow it to regain circulation and regenerate," said DiNucci.
Research finds Statin simvastatin appears to prevent or reverse vascular injury in diabetic ratsApril 3rd, 2005 Since most patients with diabetes die from some vascular complication, Medical College of Georgia researchers set out to determine the effects of simvastatin on endothelial cell dysfunction, an early pivotal event in atherogenesis and a major cause of the microvascular complications in diabetics. The researchers found that in addition to lowering cholesterol levels, simvastatin also appeared to prevent or reverse vascular injury by vasoprotective means.
Comment Below | 
Email this Article
Loading ...